Stock data
Nuvation Bio Inc. (NUVB)
Nuvation Bio Inc. (NUVB) reported revenue of US$62.90M and net income of -US$204.63M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$62.90M | — | -US$213.06M | -US$204.63M | — |
| 2024 | US$7.87M | US$0.80M | -US$592.63M | -US$567.94M | — |
| 2023 | US$0.00M | US$0.00M | -US$99.82M | -US$75.80M | — |
| 2022 | — | — | -US$119.73M | -US$104.20M | — |
| 2021 | — | — | -US$93.32M | -US$86.85M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$31.69M | -US$62.84M | — |
| 2026-03-31 | US$83.23M | US$5.40M | — |
| 2025-09-30 | US$13.12M | -US$55.79M | — |
| 2025-06-30 | US$4.83M | -US$59.01M | — |
| 2025-03-31 | US$3.08M | -US$53.24M | — |
| 2024-12-31 | US$5.71M | -US$49.45M | — |
| 2024-09-30 | US$0.73M | -US$41.21M | — |
| 2024-06-30 | US$1.44M | -US$462.49M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.